163 related articles for article (PubMed ID: 37081422)
1. Diagnostic performance of eNose technology in COVID-19 patients after hospitalization.
van Raaij BFM; Veltman JD; Hameete JF; Stöger JL; Geelhoed JJM
BMC Pulm Med; 2023 Apr; 23(1):134. PubMed ID: 37081422
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
[TBL] [Abstract][Full Text] [Related]
4. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
[TBL] [Abstract][Full Text] [Related]
5. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
[TBL] [Abstract][Full Text] [Related]
6. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
7. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
8. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis.
Licht JC; Seidl E; Slingers G; Waters V; de Vries R; Post M; Ratjen F; Grasemann H
J Cyst Fibros; 2023 Sep; 22(5):888-893. PubMed ID: 36849333
[TBL] [Abstract][Full Text] [Related]
9. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.
Moor CC; Oppenheimer JC; Nakshbandi G; Aerts JGJV; Brinkman P; Maitland-van der Zee AH; Wijsenbeek MS
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732331
[TBL] [Abstract][Full Text] [Related]
11. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive breath monitoring with eNose does not improve glucose diagnostics in critically ill patients in comparison to continuous glucose monitoring in blood.
Leopold JH; Bos LDJ; Colombo C; Sterk PJ; Schultz MJ; Abu-Hanna A
J Breath Res; 2017 Apr; 11(2):026002. PubMed ID: 28260695
[TBL] [Abstract][Full Text] [Related]
13. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
[TBL] [Abstract][Full Text] [Related]
15. Post-COVID syndrome screening through breath analysis using electronic nose technology.
V R N; Mohapatra AK; V K U; Lukose J; Kartha VB; Chidangil S
Anal Bioanal Chem; 2022 May; 414(12):3617-3624. PubMed ID: 35303135
[TBL] [Abstract][Full Text] [Related]
16. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
17. Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis.
van der Schee MP; Fens N; Brinkman P; Bos LD; Angelo MD; Nijsen TM; Raabe R; Knobel HH; Vink TJ; Sterk PJ
J Breath Res; 2013 Mar; 7(1):016002. PubMed ID: 23257711
[TBL] [Abstract][Full Text] [Related]
18. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology.
Zamora-Mendoza BN; Sandoval-Flores H; Rodríguez-Aguilar M; Jiménez-González C; Alcántara-Quintana LE; Berumen-Rodríguez AA; Flores-Ramírez R
Talanta; 2023 May; 256():124299. PubMed ID: 36696734
[TBL] [Abstract][Full Text] [Related]
19. The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.
Subali AD; Wiyono L; Yusuf M; Zaky MFA
Diagn Microbiol Infect Dis; 2022 Feb; 102(2):115589. PubMed ID: 34879323
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
